Company profile
HeartVista, Inc.
HeartVista, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on October 18, 2019 and the most recent on October 18, 2019 (RTHawk, HeartVista Cardiac Package). Its most common review panel is Radiology (1 device).
1AI devices
2019First decision
2019Latest decision
1Specialties
Timeline
- RTHawk, HeartVista Cardiac Package · Radiology · LNH